TwinStrand Biosciences discusses Duplex Sequencing I AACR 2019

Jesse Salk, MD, PhD, Co-Founder, CEO, TwinStrand Biosciences Duplex Sequencing is an NGS error-correction method which increases accuracy by more than 10,000-fold and enables high-confidence detection of ultra-rare mutations. Here we present applications of Duplex Sequencing in early cancer detection, monitoring for residual disease, evolution of drug resistance and cancer risk assessment of new drugs and chemicals.